Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Oncocyte Corp (NY: OCX )

5.850 USD +1.090 (+22.90%)
Official Closing Price Updated: 8:00 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Oncocyte Corp

< Previous 1 2 3 4 Next >
Thinking about buying stock in Palatin Technologies, Motus GI Holdings, Tellurian, OncoCyte, or Endra Life Sciences?
InvestorsObserver issues critical PriceWatch Alerts for PTN, MOTS, TELL, OCX, and NDRA. 
From PR Newswire
Thinking about buying stock in OncoCyte, FuelCell Energy, Evelo Biosciences, Lydall, or Prevail Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for OCX, FCEL, EVLO, LDL, and PRVL. 
From PR Newswire
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
From GlobeNewswire News Releases
Expectations Growing for a Post-Pandemic Boom In Healthcare Consolidations
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Expectations Growing for a Post-Pandemic Boom In Healthcare Consolidations
Financialnewsmedia.com News Commentary 
From PR Newswire
Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer
FN Media Group Presents USA News Group News Commentary 
From PR Newswire
Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer
From GlobeNewswire News Releases
Lifshitz & Miller LLP Announces Investigation of Acer Therapeutics Inc., Aclaris Therapeutics, Inc., Ideanomics, Inc., L Brands, Inc., Marriott International, Inc., NRC Group Holdings Corp., Omnicell,
From PR Newswire
OncoCyte Provides Corporate Update and Reports First Quarter 2019 Financial Results
OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung cancer, today reported financial and operating results for the first quarter ended... 
From GlobeNewswire News Releases
OncoCyte to Report First Quarter 2019 Financial Results on Tuesday, May 14
Company to host conference call and webcast at 4:30pm ET 
From GlobeNewswire News Releases
OncoCyte Announces Successful Completion of Analytical Validation Study and Commencement of CLIA Validation Study
Company remains on-track for DetermaVu™ commercial availability in 2H 2019 
From GlobeNewswire News Releases
Research Report Identifies Stamps, Chicken Soup for the Soul Entertainment, Marlin Business Services, OncoCyte, FBL Financial Group, and Cellectis S.A with Renewed Outlook — Fundamental Analysis, Calc
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Stamps.com Inc.... 
From GlobeNewswire News Releases
OncoCyte Provides Corporate Update and Reports Fourth Quarter and Full Year 2018 Financial Results
OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung cancer, today reported financial and operating results for the fourth quarter and... 
From GlobeNewswire News Releases
OncoCyte to Present Late Breaking Abstract at the American Thoracic Society 2019 International Conference
Poster presentation and discussion to detail compelling results from R&D Validation study of the Company’s DetermaVu™ liquid biopsy test for the early detection of lung cancer 
From GlobeNewswire News Releases
OncoCyte to Report Fourth Quarter and Full-Year 2018 Financial Results on Monday, April 1, 2019
OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced today that it will release its financial and operating results for the... 
From GlobeNewswire News Releases
OncoCyte Corporation to Present at Cowen and Company 39th Annual Health Care Conference in Boston
OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that William Annett, CEO of OncoCyte Corporation, will be... 
From GlobeNewswire News Releases
OncoCyte Announces Initiation of Analytical Validation Study
Company remains on-track for commercial availability of DetermaVu™ Lung in 2H 2019 
From GlobeNewswire News Releases
BioTime Provides Business Update Including Information on AgeX, OncoCyte and Asterias
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today provided a business update which included information on AgeX Therapeutics, Inc.... 
From GlobeNewswire News Releases
OncoCyte Announces Closing of Public Offering of Common Stock
OncoCyte Corporation (NYSE American: OCX) (“OncoCyte”), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today announced the closing of an underwritten public... 
From GlobeNewswire News Releases
OncoCyte Announces Pricing of Public Offering of Common Stock
OncoCyte Corporation (NYSE American: OCX) (“OncoCyte”), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today announced the pricing of an underwritten public... 
From GlobeNewswire News Releases
OncoCyte Announces Proposed Public Offering of Common Stock
OncoCyte Corporation (NYSE American: OCX) (“OncoCyte”), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today announced that it intends to offer and sell... 
From GlobeNewswire News Releases
Thinking about buying stock in Aurora Cannabis Inc., Advanced Micro Devices, Biotime Inc., Oncocyte Corp. or PG&E Corp.?
InvestorsObserver issues critical PriceWatch Alerts for ACB, AMD, BTX, OCX, and PCG. 
From PR Newswire
OncoCyte Announces Successful Results of DetermaVu™ R&D Validation Study
OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced positive results from its key R&D Validation study demonstrating... 
From GlobeNewswire News Releases
OncoCyte Schedules Announcement and Conference Call to Discuss Results from Key R&D Validation Study of DetermaVu™
Conference call scheduled for Tuesday, January 29, 2019 at 8:30am ET 
From GlobeNewswire News Releases
OncoCyte Announces Transition to Ion Torrent Next-Generation Sequencing Platform
Ion GeneStudio™ S5 Demonstrates Generation of Consistent and Reproducible Results in Lung Cancer Studies 
From GlobeNewswire News Releases
OncoCyte Provides Progress Update on Ongoing Studies
Results of Key R&D Validation Study expected in January 
From GlobeNewswire News Releases
OncoCyte Corporation to Present at the LD Micro 11th Annual Main Event Investor Conference
OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung cancer, today announced that the Company will provide a corporate overview at the LD... 
From GlobeNewswire News Releases
Report: Developing Opportunities within Summit Midstream Partners, LP, Empire State Realty Trust, Expeditors International of Washington, Ellington Residential Mortgage REIT, OncoCyte, and Sachem Capi
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Summit Midstream Partners,... 
From GlobeNewswire News Releases
OncoCyte Corporation to Present at the Piper Jaffray 30th Annual Health Care Conference
OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung cancer, today announced that the Company will provide a corporate overview at the... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account